Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.

R, Hadad; MJ, Cole; S, Ebeyan; S, Jacobsson; LY, Tan; D, Golparian; S, Erskine; M, Day; D, Whiley; M, Unemo

doi:10.1093/jac/dkaa381

Public

Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.

Shared by NobleBlocks on Jan 1, 2021 • 12:00 AM UTC

Authors:

Hadad R

Cole MJ

Ebeyan S

Abstract

Background Accurate molecular assays for prediction of antimicrobial resistance (AMR)/susceptibility in Neisseria gonorrhoeae (Ng) can offer individualized treatment of gonorrhoea and enhanced AMR surveillance.Objectives We evaluated the new ResistancePlus® GC assay and the GC 23S 2611 (beta) assay ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!